Kyverna Therapeutics (KYTX) Interest & Investment Income (2023 - 2026)
Kyverna Therapeutics (KYTX) posted Interest & Investment Income of $2.3 million for Q1 2026, up 22.15% on a QoQ basis from $1.9 million in Q4 2025, and down 17.63% year-over-year from $2.8 million in Q1 2025.
Kyverna Therapeutics (KYTX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Kyverna Therapeutics' Interest & Investment Income history runs 4 years deep, the most recent figure standing at $2.3 million for Q1 2026.
- Quarterly Interest & Investment Income fell 17.63% year-over-year to $2.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.6 million (down 44.36% YoY) and the FY2025 annual result came in at $9.1 million, down 40.79% from the prior year.
- Interest & Investment Income was $2.3 million for Q1 2026 at Kyverna Therapeutics, up from $1.9 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $4.7 million in Q2 2024 and bottomed at $264000.0 in Q2 2023.
- A 4-year average of $2.2 million and a median of $2.3 million in 2026 frame the typical range for Interest & Investment Income.
- Annual changes were most pronounced in 2024 — Interest & Investment Income soared 1678.03% — and 2025, when it tumbled 54.08%.
- Kyverna Therapeutics' Interest & Investment Income stood at $789000.0 in 2023, then soared by 353.11% to $3.6 million in 2024, then tumbled by 46.71% to $1.9 million in 2025, then rose by 22.15% to $2.3 million in 2026.
- Business Quant data shows KYTX's Interest & Investment Income at $2.3 million in Q1 2026, $1.9 million in Q4 2025, and $2.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Kyverna Therapeutics | 447.52 Mn | 447.52 Mn | - | 2.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.33 Mn |
| Dec 31, 2025 | 1.91 Mn |
| Sep 30, 2025 | 2.00 Mn |
| Jun 30, 2025 | 2.36 Mn |
| Mar 31, 2025 | 2.83 Mn |
| Dec 31, 2024 | 3.58 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 4.69 Mn |
| Mar 31, 2024 | 2.74 Mn |
| Dec 31, 2023 | 789,000.00 |
| Sep 30, 2023 | 880,000.00 |
| Jun 30, 2023 | 264,000.00 |
| Mar 31, 2023 | 349,000.00 |